학술논문

Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus Coinfection
Document Type
article
Source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 19 (2022)
Subject
cardiovascular disease
coinfection
hepatitis C virus
HIV
myocardial infarction
Diseases of the circulatory (Cardiovascular) system
RC666-701
Language
English
ISSN
2047-9980
Abstract
Background People with HIV (PWH) are at an increased risk of cardiovascular disease (CVD) with an unknown added impact of hepatitis C virus (HCV) coinfection. We aimed to identify whether HCV coinfection increases the risk of type 1 myocardial infarction (T1MI) and if the risk differs by age. Methods and Results We used data from NA‐ACCORD (North American AIDS Cohort Collaboration on Research and Design) from January 1, 2000, to December 31, 2017, PWH (aged 40–79 years) who had initiated antiretroviral therapy. The primary outcome was an adjudicated T1MI event. Those who started direct‐acting HCV antivirals were censored at the time of initiation. Crude incidence rates per 1000 person‐years were calculated for T1MI by calendar time. Discrete time‐to‐event analyses with complementary log–log models were used to estimate adjusted hazard ratios and 95% CIs for T1MI among those with and without HCV. Among 23 361 PWH, 4677 (20%) had HCV. There were 89 (1.9%) T1MIs among PWH with HCV and 314 (1.7%) among PWH without HCV. HCV was not associated with increased T1MI risk in PWH (adjusted hazard ratio, 0.98 [95% CI, 0.74–1.30]). However, the risk of T1MI increased with age and was amplified in those with HCV (adjusted hazard ratio per 10‐year increase in age, 1.85 [95% CI, 1.38–2.48]) compared with those without HCV (adjusted hazard ratio per 10‐year increase in age,1.30 [95% CI, 1.13–1.50]; P